To meet rising global demand, Siegfried is significantly expanding its sterile eye drop capacity at its El Masnou site near Barcelona. The move reinforces its role as a key supplier for the European ophthalmic market and complements its U.S. operations in Irvine. The new capacity will be available from 2027.

Sumitomo Seika Chemicals has completed construction of a dedicated pilot plant for super absorbent polymers (SAPs) at its Himeji Works in Hyogo Prefecture. The facility is intended to support the company’s efforts to develop next-generation SAP products.

Sanofi and Blueprint Medicines Corporation have entered into an agreement under which Sanofi plans to acquire the US biopharmaceutical company Blueprint for 9.1 billion dollars.

A demonstration plant with a capacity of 28 tons of ammonia per day will first be built at Uniper’s Gelsenkirchen-Scholven site in Germany. This project will serve as the basis for the planned hydrogen import terminal in Wilhelmshaven, northwestern Germany, where the technology will be applied on a large industrial scale.

Chemical recycling in Europe could rival virgin plastics production within 20–30 years — but only with over 400 billion euors in investment and strong regulatory support. A new Bain & Company report outlines the path forward and what plastics producers must do now to lead the transition.

Under a long-term offtake agreement between Exxonmobil and Marubeni, Exxonmobil will supply approximately 250,000 tonnes of low-carbon ammonia per year from its facility in Baytown, Texas to Marubeni.

Plug Power’s hydrogen plant in Woodbine, Georgia successfully produced 300 metric tons of liquid hydrogen in April 2025. This has set a production record for the U.S. hydrogen industry.

The groundbreaking of Again’s new acetic acid production facility in Texas City marks a key step toward commercializing sustainable chemicals from recycled CO2. Supported by Helm and Diamond Infrastructure Solutions, the project aims to deliver low-emission chemical solutions while strengthening local supply chains and industrial resilience.

Expanding its focus on neurodegenerative diseases, Sanofi plans to acquire Vigil Neuroscience in a deal worth up to 570 million dollars. The move brings VG-3927, a potential Alzheimer’s treatment, into Sanofi’s early-stage pipeline and builds on an earlier strategic investment.

Speciality chemicals company Evonik and Gas Malaysia are joining forces to boost renewable energy with the country’s first biomethane injection site. Using Evonik’s Sepuran Green membrane technology, the partnership marks a milestone in Malaysia’s transition to cleaner energy sources.